Data in support of a cytokine imbalance toward self-antigens come from studies in our laboratory that measured cytokine responses to native and mutated insulin B chain peptides using a cytokine enzyme linked immunospot (ELISPOT) assay with peripheral blood immune cells from new-onset T1D patients as well as non-diabetic controls [40]. This evidence concerns the gene INS and type 1 diabetes mellitus.